|
NSMAF expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.121200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.108800E-01 |
| Normal-vs-Stage2 |
1.519770E-01 |
| Normal-vs-Stage3 |
1.839000E-01 |
| Normal-vs-Stage4 |
7.975600E-01 |
| Stage1-vs-Stage2 |
1.218020E-01 |
| Stage1-vs-Stage3 |
1.899780E-01 |
| Stage1-vs-Stage4 |
9.297200E-01 |
| Stage2-vs-Stage3 |
5.740800E-01 |
| Stage2-vs-Stage4 |
2.581800E-01 |
| Stage3-vs-Stage4 |
3.922000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.719800E-01 |
| Normal-vs-AfricanAmerican |
3.130000E-01 |
| Normal-vs-Asian |
3.536400E-01 |
| Caucasian-vs-AfricanAmerican |
4.734800E-01 |
| Caucasian-vs-Asian |
1.477200E-01 |
| AfricanAmerican-vs-Asian |
1.018780E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.350600E-01 |
| Normal-vs-Female |
5.085200E-01 |
| Male-vs-Female |
5.994200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.949800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.527230E-01 |
| Normal-vs-Age(61-80Yrs) |
6.870000E-01 |
| Normal-vs-Age(81-100Yrs) |
6.806400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.961840E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.596000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.958610E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.433200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.474800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.011000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.426200E-01 |
| Classical-VS-Follicular |
7.044400E-03 |
| Classical-VS-Other |
1.209970E-01 |
| Classical-VS-Normal |
7.968600E-01 |
| Tall-VS-Follicular |
1.197210E-01 |
| Tall-VS-Other |
1.301590E-01 |
| Tall-VS-Normal |
9.229000E-01 |
| Follicular-VS-Other |
6.753400E-01 |
| Follicular-VS-Normal |
3.846300E-02 |
| Other-VS-Normal |
8.264200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.278760E-01 |
| Normal-vs-N1 |
4.198400E-01 |
| N0-vs-N1 |
7.986400E-01 |
|
|
